IP Verse

Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist

Patent No. EP3470432 (titled "Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist") was filed by Regeneron Pharmaceuticals on Aug 20, 2013. The application was issued on Oct 6, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (5)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
D YOUNGJul 6, 2022D YOUNG
NEUEFEINDJul 6, 2022MAIWALD
DR H ULRICH DORRIESJul 5, 2022DORRIES
DR H ULRICH DORRIESJul 5, 2022DORRIES, HANS ULRICH , DF-MP DORRIES FRANK-MOLNIA & POHLMAN
SECERNAJul 5, 2022-

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3470432

REGENERON PHARMACEUTICALS
Application Number
EP18194745A
Filing Date
Aug 20, 2013
Status
Revoked
May 19, 2023
Publication Date
Oct 6, 2021
External Links
Slate, Register , Google Patents